v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenue $ 328,705 $ 342,411 $ 1,003,550 $ 1,038,960
Cost of sales (excluding depreciation and amortization) 64,468 103,186 195,672 320,360
Gross Profit 264,237 239,225 807,878 718,600
Operating Expenses        
Sales and marketing expenses 150,397 143,181 535,955 221,848
General and administrative expenses 1,306,839 1,149,713 3,710,795 2,262,801
Research and development expenses 100,654 231,773
Total operating expenses 1,557,890 1,292,894 4,478,523 2,484,649
Other income (expense), net        
Interest income (expense), net (60,854) 47,845 (29,100) 47,845
Other income, net 11,767 30,804
Total Other Income (expense) (49,087) 47,845 1,704 47,845
Loss before provision for income taxes (1,342,740) (1,005,824) (3,668,941) (1,718,204)
Income tax benefit (expense), net
Net loss (1,342,740) (1,005,824) (3,668,941) (1,718,204)
Comprehensive loss $ (1,342,740) $ (1,005,824) $ (3,668,941) $ (1,718,204)
Net loss per share - Basic [1] $ (0.11) $ (0.08) $ (0.30) $ (0.16)
Net loss per share - Diluted [1] $ (0.11) $ (0.08) $ (0.30) $ (0.16)
Weighted average number of shares outstanding - Basic [1] 12,144,768 11,873,799 12,135,724 10,645,448
Weighted average number of shares outstanding - Diluted [1] 12,144,768 11,873,799 12,135,724 10,645,448
[1] Shares and per share data are presented on a retroactive basis to reflect a 1.2-for-1 reverse stock split of the common stock which occurred on January 15, 2025. See Note 7(B).